EDNEF (Eden Empire) OCF Margin %: -62.75% (As of Apr. 2022)


What is Eden Empire OCF Margin %?

Eden Empire EDNEF OCF Margin % is -62.75% as of Apr. 2022.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Eden Empire's Cash Flow from Operations for the three months ended in Apr. 2022 was $-0.03 Mil. Eden Empire's Revenue for the three months ended in Apr. 2022 was $0.05 Mil. Therefore, Eden Empire's OCF Margin % for the quarter that ended in Apr. 2022 was -62.75%.

As of today, Eden Empire's current OCF Yield % is -151,000.00%.

The historical rank and industry rank for Eden Empire's OCF Margin % or its related term are showing as below:

EDNEF' s OCF Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: -592.64


EDNEF's OCF Margin % is not ranked
in the Drug Manufacturers industry.
Industry Median: 9.95 vs EDNEF: -592.64


Eden Empire OCF Margin % Related Terms


Eden Empire OCF Margin % Historical Data

* Premium members only.

The historical data trend for Eden Empire's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eden Empire OCF Margin % Chart

Eden Empire Annual Data
Trend Jul19 Jul20 Jul21
OCF Margin %
0.00 0.00 -1,102.30

Eden Empire Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -255.13 -970.83 -10.45 -2,341.18 -62.75

EDNEF vs ZTS, CTLT, VTRS: OCF Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Eden Empire's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eden Empire OCF Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eden Empire's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Eden Empire's OCF Margin % falls into.



Eden Empire OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Eden Empire's OCF Margin for the fiscal year that ended in Jul. 2021 is calculated as

OCF Margin=Cash Flow from Operations (A: Jul. 2021 )/Revenue (A: Jul. 2021 )
=-1.918/0.174
=-1,102.30 %

Eden Empire's OCF Margin for the quarter that ended in Apr. 2022 is calculated as

OCF Margin=Cash Flow from Operations (Q: Apr. 2022 )/Revenue (Q: Apr. 2022 )
=-0.032/0.051
=-62.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -62.75% mean?
Eden Empire (EDNEF) has a OCF Margin % of -62.75% as of Apr. 2022. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eden Empire and its competitors.
Is Eden Empire's OCF Margin % too high?
Eden Empire's current OCF Margin % is -62.75%.
How does Eden Empire's OCF Margin % compare to ZTS and CTLT?
Eden Empire's OCF Margin % of -62.75% can be compared against companies in the Drug Manufacturers industry. The industry median OCF Margin % is 9.95. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.95, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Eden Empire and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eden Empire's current OCF Margin % is -62.75%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eden Empire stock overvalued right now?
Eden Empire (EDNEF) has a current OCF Margin % of -62.75%. The current OCF Margin % is -62.75%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Eden Empire (EDNEF), the current OCF Margin % is -62.75% as of Apr. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eden Empire Business Description

Address The Stack, 1133 Melville Street, Suite 2700, Vancouver, BC, CAN, V6E 4E5
Eden Empire Inc is engaged in the business of operating and investing in the retail cannabis sector.